Home/Filings/4/0001209191-23-003999
4//SEC Filing

Shetzline Michael 4

Accession 0001209191-23-003999

CIK 0001446847other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:05 PM ET

Size

4.8 KB

Accession

0001209191-23-003999

Insider Transaction Report

Form 4
Period: 2023-01-17
Shetzline Michael
SVP, CMO, Head-Res&Drug
Transactions
  • Award

    Class A Common Stock

    2023-01-17+14,663280,908 total
Footnotes (1)
  • [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted February 27, 2020 and April 24, 2020. The earned PSUs were certified and vested on January 17, 2023.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001808509

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:05 PM ET
Size
4.8 KB